Independent validation of performance Merlin Test in Swedish patients

ROTTERDAM, Netherlands and SAN DIEGO, March 24, 2022 /PRNewswire/ — Today, SkylineDx announced that their Merlin Test for melanoma patients was independently validated in a Swedish (European) cohort, where it could reduce approximately a third of the surgeries in the clinically most…

Click here to view original post